Introduction: Who Should Be Tested for Breast Cancer

Breast cancer diagnosis begins long before you walk into a doctor’s office with concerns. It starts with awareness and routine screening, especially for women who may not have any symptoms at all. Many breast cancers are discovered during regular mammograms, which are X-ray images of the breast, rather than because someone felt a lump or noticed changes.^[1]

Women should begin regular breast cancer screening according to their doctor’s recommendations, which typically start around age 40 or 50 depending on individual risk factors. However, younger women with a family history of breast cancer or known genetic mutations may need to start screening much earlier. The decision about when to begin screening is personal and should be made together with your healthcare provider.^[10]

You should seek diagnostic testing immediately if you notice any changes in your breasts. These changes might include finding a lump or area of thickening in your breast or underarm, noticing that your breast has changed in size or shape, seeing dimpling or puckering of the breast skin, or experiencing changes to your nipple such as turning inward or unusual discharge. Some breast cancers cause the skin to look red, swollen, or feel warm, like an orange peel texture. While breast pain alone is rarely a sign of cancer, any persistent pain should be evaluated.^[1]

Women with certain risk factors may need more frequent or earlier screening. These risk factors include having a mother, sister, or daughter who had breast cancer, carrying genetic mutations like BRCA1 or BRCA2 (genes that, when changed, increase cancer risk), having had radiation therapy to the chest before age 30, or having previously been diagnosed with breast cancer. Dense breast tissue, which appears white on mammograms and makes it harder to see tumors, is another reason to discuss additional screening methods with your doctor.^[6]

Classic Diagnostic Methods for Breast Cancer

Clinical Breast Examination

A clinical breast exam is often the first step when breast cancer is suspected. During this exam, a healthcare professional carefully looks at and feels your breasts and the areas around them. They check for any lumps, changes in skin texture, nipple changes, or anything that seems unusual. The doctor also examines the area under your arms and along your collarbones, where lymph nodes (small bean-shaped structures that filter body fluids and help fight infection) can sometimes be felt if cancer has spread.^[10]

Mammography

Mammography is the most common and important screening tool for breast cancer. During a mammogram, your breast is placed on a platform and gently compressed while an X-ray image is taken. This compression might feel uncomfortable for a moment, but it helps create a clear picture by spreading out the breast tissue. Mammograms can detect tiny lumps or abnormal areas that are too small to feel during a physical exam.^[10]

If a screening mammogram shows something that needs closer investigation, you may be asked to return for a diagnostic mammogram. This is a more detailed exam that takes additional images from different angles and magnified views of the suspicious area. Diagnostic mammograms help doctors determine whether the finding is likely to be cancer or something benign like a fluid-filled cyst (a sac containing fluid).^[10]

Breast Ultrasound

An ultrasound uses sound waves to create images of the inside of your breast. Unlike X-rays, ultrasound does not use radiation. A technician applies gel to your breast and moves a handheld device called a transducer across your skin. The sound waves bounce off breast tissue and create images on a screen. Ultrasound is particularly helpful for determining whether a lump is solid or filled with fluid. It can also guide doctors when they need to take a tissue sample from a specific area.^[10]

Magnetic Resonance Imaging (MRI)

A breast MRI uses magnets and radio waves instead of X-rays to create detailed images of breast tissue. During the procedure, you lie face down on a padded table with openings for your breasts. The table slides into a large tube-shaped machine. Sometimes a contrast dye is injected into your vein to help certain tissues show up more clearly. MRI is very sensitive and can detect cancers that mammograms might miss, especially in women with dense breast tissue. However, MRI can also show things that turn out not to be cancer, which may lead to additional tests.^[10]

Breast Biopsy

A biopsy is the only way to confirm whether a suspicious area is truly cancer. During a biopsy, a small sample of breast tissue is removed and sent to a laboratory where doctors who specialize in examining tissues, called pathologists, look at it under a microscope. There are several types of breast biopsies, ranging from using a thin needle to remove a small amount of fluid or cells, to using a larger hollow needle to remove a core of tissue, to surgically removing part or all of a lump.^[10]

Most biopsies are done using a technique where the doctor uses imaging like ultrasound or mammography to guide the needle to exactly the right spot. This is less invasive than surgery and can usually be done with local numbing medicine while you are awake. For very small or hard-to-find abnormalities, a technique called stereotactic biopsy uses mammogram images from two different angles to pinpoint the exact location.^[10]

Laboratory Testing of Tumor Samples

Once cancer cells are confirmed, the tissue sample undergoes additional laboratory tests to understand the specific characteristics of the cancer. These tests look for certain proteins on the surface of cancer cells. Some breast cancers have receptors that respond to the hormones estrogen or progesterone (female hormones that can fuel cancer growth). These are called hormone receptor-positive cancers. Other cancers have high levels of a protein called HER2, which helps cancer cells grow quickly. These are called HER2-positive cancers.^[2]

Understanding which receptors or proteins your cancer has is crucial because it guides treatment decisions. Some cancers have none of these receptors or proteins and are called triple-negative breast cancer. Each type responds differently to treatment, so knowing exactly what kind of breast cancer you have helps doctors choose the most effective approach.^[2]

Additional Imaging for Staging

If breast cancer is confirmed, additional tests may be done to determine whether cancer has spread beyond the breast. These might include chest X-rays to check the lungs, bone scans to look for cancer in bones, CT scans to examine the abdomen and chest in detail, or PET scans that can detect cancer throughout the body. These imaging tests help doctors understand the stage of the cancer, which describes how large the tumor is and whether it has spread to lymph nodes or other parts of the body.^[6]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new ways to prevent, detect, or treat breast cancer. These trials help researchers understand whether new treatments are safe and effective. If you are considering joining a clinical trial, you will need to undergo specific diagnostic tests to determine whether you qualify for participation.^[11]

Most clinical trials have strict eligibility criteria (requirements that participants must meet). These criteria ensure that the trial enrolls patients who are most likely to benefit from the experimental treatment and whose results can provide meaningful scientific information. The diagnostic tests required for trial qualification typically go beyond standard diagnosis and may be more detailed or frequent.^[14]

Pathology Confirmation and Receptor Testing

Clinical trials almost always require recent pathology confirmation that you have breast cancer. This means your tissue samples must be reviewed and confirmed by a pathologist, sometimes at the institution running the trial. The cancer’s receptor status—whether it is estrogen receptor-positive, progesterone receptor-positive, HER2-positive, or triple-negative—must be clearly documented. Some trials are designed specifically for one type of breast cancer, so your cancer must match the type being studied.^[11]

Staging and Imaging Studies

Clinical trials often specify which cancer stages are eligible. To determine your stage accurately, you may need comprehensive imaging studies including mammograms, breast MRI, chest CT scans, abdominal CT scans, bone scans, or PET scans. These tests show whether cancer is confined to the breast, has spread to nearby lymph nodes, or has reached distant organs. Trials might be designed for early-stage cancer that hasn’t spread, locally advanced cancer that has grown into nearby tissues, or metastatic cancer that has spread to distant parts of the body.^[11]

Blood Tests and Organ Function

Before enrolling in a clinical trial, you will likely need blood tests to check your overall health. These tests measure things like your blood cell counts, liver function, kidney function, and heart health. Clinical trials often require that these values fall within certain ranges to ensure you are healthy enough to tolerate the experimental treatment and that the treatment can be given safely. Poor organ function might make some treatments too risky.^[6]

Genetic Testing

Some clinical trials focus on patients who have specific genetic mutations. If you have a family history suggesting inherited breast cancer risk, you might undergo genetic testing to look for mutations in genes like BRCA1, BRCA2, or other genes associated with breast cancer. These tests use a blood sample or saliva sample to analyze your DNA. If you carry certain mutations, you might qualify for trials testing new drugs that specifically target cancers caused by those genetic changes.^[6]

Cardiac Assessment

Some breast cancer treatments, particularly certain chemotherapy drugs and HER2-targeted therapies, can affect the heart. Clinical trials testing these types of treatments usually require baseline heart testing before you start. This might include an echocardiogram (an ultrasound of your heart) or a MUGA scan (a nuclear medicine test that measures how well your heart pumps blood). Your heart function will be checked periodically during the trial to ensure the treatment is not causing heart damage.^[6]

Tumor Tissue for Research

Many clinical trials require that you provide tumor tissue samples for research purposes. This might mean sending samples from your original biopsy or surgery to the trial’s central laboratory. In some cases, you may need to undergo an additional biopsy specifically for the trial. These tissue samples help researchers understand how the cancer responds to treatment at the molecular level and may lead to discoveries about how to improve treatment in the future.^[11]

Performance Status Evaluation

Clinical trials assess your ability to carry out daily activities, called your performance status. This is usually measured on a scale that rates how well you can care for yourself and how much time you spend in bed or resting. Trials typically require that you are well enough to be up and active for most of the day. This helps ensure you are strong enough to handle the treatment being studied and reduces the risk of complications.^[14]

Previous Treatment History

Your previous cancer treatments matter when determining trial eligibility. Some trials are designed for patients who have never received treatment before, while others are specifically for those whose cancer has returned after previous therapy. You will need detailed records of any surgery, radiation, chemotherapy, hormone therapy, or targeted therapy you have received. The timing of your last treatment also matters, as some trials require a waiting period between previous treatment and trial enrollment.^[11]